Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Primary liver cancer is a rising cause of cancer deaths in the US. Although immunotherapy with immune checkpoint inhibitors induces a potent response in a subset of patients, response rates vary among individuals. Predicting which patients will respond to immune checkpoint inhibitors is of great int...

Descripción completa

Detalles Bibliográficos
Autores principales: Budhu, Anuradha, Pehrsson, Erica C., He, Aiwu, Goyal, Lipika, Kelley, Robin Kate, Dang, Hien, Xie, Changqing, Monge, Cecilia, Tandon, Mayank, Ma, Lichun, Revsine, Mahler, Kuhlman, Laura, Zhang, Karen, Baiev, Islam, Lamm, Ryan, Patel, Keyur, Kleiner, David E., Hewitt, Stephen M., Tran, Bao, Shetty, Jyoti, Wu, Xiaolin, Zhao, Yongmei, Shen, Tsai-Wei, Choudhari, Sulbha, Kriga, Yuliya, Ylaya, Kris, Warner, Andrew C., Edmondson, Elijah F., Forgues, Marshonna, Greten, Tim F., Wang, Xin Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313915/
https://www.ncbi.nlm.nih.gov/pubmed/37224815
http://dx.doi.org/10.1016/j.xcrm.2023.101052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313915/
https://www.ncbi.nlm.nih.gov/pubmed/37224815
http://dx.doi.org/10.1016/j.xcrm.2023.101052

Ejemplares similares